{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q95SP2",
      "entity_text" : "synoviolin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03504",
      "entity_text" : "LS-101",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Since LS-101, a nonselective inhibitor, reduced clinical severity scores in CIA similarly to LS-102, blocking synoviolin enzymatic activity seems crucial in the pathological process of CIA.",
  "reading_complete" : "2020-08-02T13:51:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:49:48Z",
  "trigger" : "reduced",
  "evidence" : [ "LS-101, a nonselective inhibitor, reduced clinical severity scores in CIA similarly to\nLS-102, blocking synoviolin" ],
  "pmc_id" : "4042867",
  "score" : 0
}